Table 6: Secondary analysis of factors associated with clinical malaria in pregnancy.
| Variable | Treated for MIP | |||
| COR (95%CI) | P-value | AOR (95% CI) | P-value | |
| Maternal age | ||||
| 14-20 years | 1 | 1 | ||
| 21-30 years | 0.51 (0.30-0.85) | 0.009 | 0.57 (0.33-0.99) | 0.047 |
| 31-40 years | 0.40 (0.20-0.64) | 0.005 | 0.45 (0.25-0.70) | 0.03 |
| Gravidity | ||||
| Paucigravidae (G1/G2) | 1 | 1 | ||
| Multigravidae (≥ G3) | 0.80 (0.53-1.22) | 0.3 | 0.82 (0.56-1.30) | 0.35 |
| ANC visits | ||||
| < 4 visits | 1 | 1 | ||
| ≥ 4 visits | 0.64 (0.43-0.96) | 0.031 | 1.23 (0.76-2.03) | 0.398 |
| SP doses taken | ||||
| < 3 doses | 1 | 1 | ||
| ≥ 3 doses | 0.33 (0.19-0.53) | < 0.001 | 0.30 (0.17-0.54) | < 0.001 |
ANC = Antenatal care; SP = Sulphadoxine-pyrimethamine; MIP = Malaria in pregnancy; 95% CI = 95% confidence interval; Significant p-values are presented in bold.